Linked Life Data

17013332

Source:http://linkedlifedata.com/resource/pubmed/id/17013332

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-10-2
pubmed:abstractText
Most drugs used in the care of children have never had appropriate studies conducted by the manufacturer which fulfill Food and Drug Administration requirements necessary to be included in the 'indications' portion of the package insert. Any use not described in the indications of the package insert is considered 'off-label'. A number of editorials and hard work by many individuals have all resulted in new legislation that hopefully will start to make the necessary changes in drug development. This paper will review the pertinent issues.
pubmed:language
eng
pubmed:journal
pubmed:status
PubMed-not-MEDLINE
pubmed:month
Jun
pubmed:issn
0952-7907
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
325-7
pubmed:year
1999
pubmed:articleTitle
'Off-label' use of drugs in pediatric anesthesia: legal, clinical and policy considerations.
pubmed:affiliation
Department of Pediatric Anesthesiology, Children's Memorial Hospital, Chicago, IL 60614, USA. ccote@nwu.edu
pubmed:publicationType
Journal Article